263 related articles for article (PubMed ID: 7750536)
1. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
Minami M; Onogi T; Nakagawa T; Katao Y; Aoki Y; Katsumata S; Satoh M
FEBS Lett; 1995 May; 364(1):23-7. PubMed ID: 7750536
[TBL] [Abstract][Full Text] [Related]
2. DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.
Onogi T; Minami M; Katao Y; Nakagawa T; Aoki Y; Toya T; Katsumata S; Satoh M
FEBS Lett; 1995 Jan; 357(1):93-7. PubMed ID: 8001688
[TBL] [Abstract][Full Text] [Related]
3. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
4. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
Wang WW; Shahrestanifar M; Jin J; Howells RD
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
[TBL] [Abstract][Full Text] [Related]
5. DAMGO recognizes four residues in the third extracellular loop to discriminate between mu- and kappa-opioid receptors.
Seki T; Minami M; Nakagawa T; Ienaga Y; Morisada A; Satoh M
Eur J Pharmacol; 1998 Jun; 350(2-3):301-10. PubMed ID: 9696421
[TBL] [Abstract][Full Text] [Related]
6. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
7. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes.
Mignat C; Wille U; Ziegler A
Life Sci; 1995; 56(10):793-9. PubMed ID: 7885194
[TBL] [Abstract][Full Text] [Related]
8. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.
Fukuda K; Terasako K; Kato S; Mori K
FEBS Lett; 1995 Oct; 373(2):177-81. PubMed ID: 7589460
[TBL] [Abstract][Full Text] [Related]
9. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
[TBL] [Abstract][Full Text] [Related]
10. The third extracellular loop of the mu opioid receptor is important for agonist selectivity.
Xue JC; Chen C; Zhu J; Kunapuli SP; de Riel JK; Yu L; Liu-Chen LY
J Biol Chem; 1995 Jun; 270(22):12977-9. PubMed ID: 7768887
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
12. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
14. On the role of extracellular loops of opioid receptors in conferring ligand selectivity.
Metzger TG; Ferguson DM
FEBS Lett; 1995 Nov; 375(1-2):1-4. PubMed ID: 7498453
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of cyanogen bromide on ligand binding by mu, delta and kappa opioid receptors.
Hiller JM; Fan LQ; Simon EJ
Life Sci; 1990; 47(24):2225-30. PubMed ID: 2176264
[TBL] [Abstract][Full Text] [Related]
17. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
18. Mu and delta opioids but not kappa opioid inhibit voltage-activated Ba2+ currents in neuronal F-11 cell.
Nah SY; Unteutsch A; Bunzow JR; Cook SP; Beacham DW; Grandy DK
Brain Res; 1997 Aug; 766(1-2):66-71. PubMed ID: 9359588
[TBL] [Abstract][Full Text] [Related]
19. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
20. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
